Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01698528 · ClinicalTrials.gov registry record · NA

Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration

A NA study of Type II Diabetes, sponsored by Joslin Diabetes Center.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT01698528: Completed NA study of Type II Diabetes, sponsored by Joslin Diabetes Center.

NCT01698528 is a NA study of Type II Diabetes that has completed, run by Joslin Diabetes Center. The registered enrollment target is 40 participants, below the 675-participant average among 6 other Type II Diabetes trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01698528, a NA study of Type II Diabetes, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if using a diabetes management technology system, including a tablet computer, to track diabetes care and communicate with a clinician coach (a doctor or nurse from the Joslin Clinic) makes starting and adjusting insulin easier and safer for people with type 2 diabetes. Hypothesis: The use of a diabetes management technology system with a clinician coach helps more individuals starting basal insulin achieve better glycemic control with less hypoglycemia compared with standard clinical practice at Joslin Diabetes Center.

Primary Outcome

The primary outcome of interest is absolute decrease in A1c by end of 3 months.

Conditions Studied

Interventions

  • DEVICE Tablet Computer

Study Locations (1)

Massachusetts

  • Joslin Diabetes Center - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2012-10
Est. Completion 2015-10
Phase NA
Joslin Diabetes Center

73 total trials

What the finished NCT01698528 record still lists

NCT01698528 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 675-participant average among 6 other Type II Diabetes trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Type II Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Tablet Computer is the first listed.

NCT01698528 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01698528 about?

NCT01698528 is a clinical study titled "Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration". The purpose of this study is to determine if using a diabetes management technology system, including a tablet computer, to track diabetes care and communicate with a clinician coach (a doctor or nurse from the Joslin Clinic) makes starting and adjusting insulin easier and safer for people with type...

What is the current status of trial NCT01698528?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-10. Estimated completion is 2015-10.

What conditions does trial NCT01698528 study?

This clinical trial studies the following conditions: Type II Diabetes.

What interventions are being tested in trial NCT01698528?

The interventions under investigation include: Tablet Computer (DEVICE).

Who is sponsoring clinical trial NCT01698528?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01698528 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type II Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01698528, the US trial registry maintained by the National Library of Medicine. NCT01698528 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.